Press Release
Category Added in a WPeMatico Campaign
-
Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering
SAN FRANCISCO, April 21, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative…
Read More » -
Trading Technologies and Mercantile Exchange of Vietnam Agree to Offer MXV Members Access to Global Derivatives Markets Through TT® Infrastructure
CHICAGO and HANOI, Vietnam, April 21, 2026 /PRNewswire/ — Trading Technologies International, Inc. (TT), a global capital markets technology platform…
Read More » -
Kelun-Biotech Announces Three Clinical Study Results Selected for Oral Presentations at 2026 ASCO Annual Meeting
CHENGDU, China, April 21, 2026 /PRNewswire/ — The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting will be held…
Read More » -
FERMI PROVIDES BUSINESS UPDATE
DALLAS, April 21, 2026 /PRNewswire/ — Fermi Inc. (d/b/a Fermi America) (NASDAQ: FRMI) (LSE: FRMI), operating as Fermi America™ (“Fermi”…
Read More » -
Slip And Fall Vs Premises Liability Explained By HelloNation Featuring Personal Injury Attorney Joe Stanley
The article clarifies how property owner responsibility and legal negligence affect injury claims under New York law. WATERTOWN, N.Y., April…
Read More » -
MAHA ACTION WELCOMES BIOTECH PIONEER LOU REESE TO ITS BOARD OF DIRECTORS
Visionary entrepreneur and health innovator joins the movement to reverse America s chronic disease epidemic WASHINGTON, Apr. 21, 2026 /PRNewswire/…
Read More » -
ViGenCell’s VT-EBV-N Selected for Oral Presentation at ASCO 2026
Phase 2 study of EBV-specific T cell therapy to be presented at a leading oncology meeting SEOUL, South Korea, April…
Read More » -
BCE reports results of Series AG and AH Preferred Share conversions
MONTRÉAL, April 21, 2026 /PRNewswire/ – BCE Inc. (TSX: BCE) (NYSE: BCE) today announced that 121,070 of its 8,032,285 fixed-rate…
Read More »